ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, announced today that Richard Faleschini, the Company’s President and Chief Executive Officer, is scheduled to present at the Roth Capital Partners 20th Annual OC Growth Stock Conference on Tuesday, February 19, 2008 at 9:00 am Pacific Time / 12:00 pm Eastern Time. The Conference is being held at The Ritz-Carlton in Laguna Niguel, California.
